Breaking News, Financial News

Financial Report: ICON

Revenues up 13% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

ICON
 
4Q Revenues: $390 million (+13%)

4Q Earnings: $54.0 million (+61%)

FY Revenues: $1.5 billion (+13%)

FY Earnings: $181.3 million (+65%)

Comments: Income from operations was $60.4 million or 16% of revenue, compared to $38.7 million or 11% in 4Q13. Net business wins in the quarter were $469 million, representing a net book to bill of 1.20. Full year new business awards were $1.8 billion, representing a net book to bill of 1.21.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters